In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The reversible S-nitrosation and inhibition of mitochondrial complex I is a potential mechanism of cardioprotection, recruited by ischemic preconditioning (IPC), S-nitrosothiols, and nitrite. Previously, to exploit this mechanism, the mitochondrial S-nitrosating agent S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) was developed, and protected perfused hearts and isolated cardiomyocytes against ischemia-reperfusion (IR) injury. In the present study, the murine left anterior descending coronary artery (LAD) occlusion model of IR injury was employed, to determine the protective efficacy of SNO-MPG in vivo. Intraperitoneal administration of 1 mg/kg SNO-MPG, 30 min. prior to occlusion, significantly reduced myocardial infarction and improved EKG parameters, following 30 min. occlusion plus 2 or 24 hr. reperfusion. SNO-MPG protected to the same degree as IPC, and notably was also protective when administered at reperfusion. Cardioprotection was accompanied by increased mitochondrial protein S-nitrosothiol content, and inhibition of complex I, both of which were reversed after 2 hr. reperfusion. Finally, hearts from mice harboring a heterozygous mutation in the complex I NDUSF4 subunit were refractory to protection by either SNO-MPG or IPC, suggesting that a fully functional complex I, capable of reversible inhibition is critical for cardioprotection. Overall, these results are consistent with a role for mitochondrial S-nitrosation and complex I inhibition in the cardioprotective mechanism of IPC and SNO-MPG in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575
Self-citationProtein S-nitrosylation: Purview and parameters
Hess, D. T., Matsumoto, A., Kim, S.-O., Marshall, H. E., & Stamler, J. S. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1569 · Cited by 2,153 · cited 6×
“Post-translational modifications to mitochondrial proteins (e.g. kinase mediated phosphorylation) have been widely recognized as playing an important role in IPC signaling [7], and more recently the mitochondrial formation of S-nitrosothiols (SNOs) has been proposed as a novel protective signaling mechanism in IPC [4,…”
BackgroundInfluentialClementi, E., Brown, G. C., Feelisch, M., & Moncada, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7631 · Cited by 863 · cited 2×
“Many proteins with important roles in energy metabolism and Ca2+ homeostasis (both critical cardiomyocyte functions) have been identified as targets of S-nitrosation, including: L-type Ca2+ channels [13], ryanodine receptor [14], sarco/endoplasmic reticulum Ca2+ ATPase [10], caspases [15], hemoglobin [16], the 75 kDa…”
BackgroundShiva, S., Sack, M. N., Greer, J. J., Duranski, M., Ringwood, L. A., Burwell, L., Wang, X., MacArthur, P. H., Shoja, A., Raghavachari, N., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070198 · Cited by 555 · cited 2×
“nitrite [25], which is about to enter clinical trials for myocardial infarction), may afford novel therapeutics for IR injury in humans.”
BackgroundSelf-citationSingel, D. J., & Stamler, J. S. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.060603.090918 · Cited by 481 · cited 1×
“Indeed, hemoglobin (Hb) has been widely reported as a target of S-nitrosation [16], and it has been proposed that SNO-Hb is essential for hypoxic vasodilatation [78,79] (although this concept has recently been challenged by the generation of a Hb-β93-Cys/Ala mutant mouse [80]).”
BackgroundThe ubiquitous role of nitric oxide in cardioprotection
Jones, S. P., & Bolli, R. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.09.011 · Cited by 434
Sun, J., Morgan, M., Shen, R.-F., Steenbergen, C., & Murphy, E. (2007) · Circulation Research · doi:10.1161/circresaha.107.155879 · Cited by 367 · cited 6×
“In addition we and others have shown that S-nitrosation of mitochondrial proteins occurs during IPC, and that the reversible inhibition of respiratory complex I appears to be an important event which may contribute to cardioprotection [4,9,10,22,44].”
BackgroundResultInfluentialDirect evidence for S-nitrosation of mitochondrial complex I
Burwell, L. S., Nadtochiy, S. M., Tompkins, A. J., Young, S., & Brookes, P. S. (2006) · Biochemical Journal · doi:10.1042/bj20051435 · Cited by 274 · cited 5×
“S-nitrosation of complex I has previously been linked to inhibition of its enzymatic activity in isolated systems such as perfused heart, cardiomyocytes and mitochondria [8,9,17,18].”
BackgroundMethodResultInfluentialSelf-citationDahm, C. C., Moore, K., & Murphy, M. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512203200 · Cited by 194
Hurd, T. R., Requejo, R., Filipovska, A., Brown, S., Prime, T. A., Robinson, A. J., Fearnley, I. M., & Murphy, M. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803432200 · Cited by 182 · cited 1×
“The role of glutathionylation in IPC overall is currently poorly understood, but ROS generation from complex I has recently been shown to be regulated by this modification, suggesting possible relevance [51].”
Background
Cited by
A Unifying Mechanism for Mitochondrial Superoxide Production during Ischemia-Reperfusion Injury
Chouchani, E. T., Pell, V. R., James, A. M., Work, L. M., Saeb-Parsy, K., Frezza, C., Krieg, T., & Murphy, M. P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.009 · Cited by 752
“These modifications include S-nitrosation by nitric oxide metabolites such as S-nitrosothiols (Kohr et al., 2011; Nadtochiy et al., 2007, 2009) and sodium nitrite (Chouchani et al., 2013; Shiva et al., 2007), S-sulfenylation by hydrogen sulfide (Elrod et al., 2007), oxidation to a sulfenic acid…”
MethodKalogeris, T., Bao, Y., & Korthuis, R. J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.05.006 · Cited by 716
Redox regulation of mitochondrial function
Handy, D. E., & Loscalzo, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4123 · Cited by 588
“Other therapeutic means to regulate ETC leak are being developed, including S-nitrosating compounds, that were discussed previously (306, 336), and cationic plastoquinone derivatives (392).”
BackgroundIschemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
Soares, R. O. S., Losada, D. M., Jordani, M. C., Évora, P., & Castro-e-Silva, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205034 · Cited by 408
Mitochondria as a Drug Target in Ischemic Heart Disease and Cardiomyopathy
Walters, A. M., Porter, G. A., & Brookes, P. S. (2012) · Circulation Research · doi:10.1161/circresaha.112.265660 · Cited by 271
Self-citation
Metadata
- Authors
- Nadtochiy, S. M., Burwell, L. S., Ingraham, C. A., Spencer, C. M., Friedman, A. E., Pinkert, C. A., & Brookes, P. S.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 46
- Issue
- 6
- Pages
- 960-968
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2156179417
- Cited by
- 72
- References
- 13
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine. https://app.cochat.ai/papers/10.1016/j.yjmcc.2009.01.012
- The paper
- Nadtochiy, S. M., Burwell, L. S., Ingraham, C. A., Spencer, C. M., Friedman, A. E., Pinkert, C. A., & Brookes, P. S. (2009). In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine. Journal of Molecular and Cellular Cardiology. https://doi.org/10.1016/j.yjmcc.2009.01.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.